View Older Stories View More Recent Stories

Jun 24, 2024 09:00AM TMRW Sports Completes Series A Investment Round, Co-led by Dynasty Equity and Connect Ventures
Jun 18, 2024 09:05AM Decagon raises $35 million for AI-powered customer service
Jun 13, 2024 10:16AM NEA Appoints Andrew Schoen and Blake Wu to Senior Investing Team Roles, Promotes Alex Sharata to Partner
Jun 11, 2024 09:00AM PostgreSQL is Now Faster than Pinecone, 75% Cheaper, with New Open Source Extensions
Jun 10, 2024 08:02AM Anterior Secures $20 Million Series A to Unlock Administrative Efficiencies for Healthcare Payers
Jun 10, 2024 03:00AM Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval
May 29, 2024 09:00AM Stride and Roadie Partner to Empower Drivers with Financial Tools
May 22, 2024 08:00AM NODAR Transforms Automated Parking By Eliminating The Need For Ultrasonic Sensors And Providing Detailed 3D Surroundview Maps
May 21, 2024 06:35PM Form SC 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
May 17, 2024 06:25PM Form SC 13D/A Marker Therapeutics, Filed by: New Enterprise Associates 16, L.P.
May 17, 2024 09:34AM Form SC 13D/A BuzzFeed, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
May 16, 2024 07:52PM Form SC 13D/A BuzzFeed, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
May 16, 2024 07:45PM Form SC 13D/A SYNLOGIC, INC. Filed by: New Enterprise Associates 14, L.P.
May 15, 2024 07:21PM Form SC 13D/A ZeroFox Holdings, Inc. Filed by: New Enterprise Associates 14, L.P.
May 13, 2024 08:41PM Form SC 13D/A Monte Rosa Therapeutics, Filed by: New Enterprise Associates 17, L.P.
May 13, 2024 07:10PM Form SC 13D/A Black Diamond Therapeuti Filed by: New Enterprise Associates 16, L.P.
May 10, 2024 04:32PM Form SC 13D/A NEXTNAV INC. Filed by: New Enterprise Associates 14, L.P.
May 9, 2024 04:05PM Regulus Therapeutics Reports First Quarter 2024 Financial Results and Recent Updates
May 8, 2024 05:07PM Form SC 13D/A GLYCOMIMETICS INC Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
May 8, 2024 04:33PM Form SC 13D/A Reneo Pharmaceuticals, Filed by: New Enterprise Associates 15, L.P.
May 8, 2024 08:30AM In-House Health Raises $4 Million Seed Round, Unveils AI-Powered Scheduling Platform to Combat Nurse Shortage Crisis
May 7, 2024 07:00AM Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs
May 6, 2024 07:46PM Form SC 13D/A CHAMPIONS ONCOLOGY, INC. Filed by: New Enterprise Associates 14, L.P.
May 3, 2024 09:23PM Form SC 13D/A Inventiva S.A. Filed by: New Enterprise Associates 17, L.P.
May 2, 2024 07:57PM Form SC 13D/A Desktop Metal, Inc. Filed by: New Enterprise Associates 15, L.P.
Apr 30, 2024 07:32PM Form SC 13D/A RHYTHM PHARMACEUTICALS, Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Apr 30, 2024 10:00AM SafeBase Raises $33M in Series B to Accelerate Vision for Friction-Free Security Reviews
Apr 30, 2024 04:00AM Merge Expands Footprint in Europe, Facilitating Product Integrations for GDPR-Compliant Companies
Apr 24, 2024 07:34PM Form SC 13D/A Korro Bio, Inc. Filed by: New Enterprise Associates 17, L.P.
Apr 19, 2024 04:14PM Form 144 Tuya Inc./ADR Filed by: New Enterprise Associates 14, L.P.
Apr 15, 2024 07:00AM AviadoBio Announces First Patient Treated in ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
Apr 10, 2024 09:52PM Form SC 13D/A NeueHealth, Inc. Filed by: New Enterprise Associates 15, L.P.
Apr 10, 2024 07:30AM Stride Launches Utah's First Independent Worker Portable Benefits Contributions Program
Apr 9, 2024 05:29PM NeueHealth Enters into Amendment to its Credit Facility
Apr 9, 2024 11:00AM Tony Florence and Mohamad Makhzoumi Named Co-CEOs of NEA; Scott Sandell Assumes Role of Executive Chairman & CIO
Apr 4, 2024 12:15PM Timescale Acquires PopSQL to Bring a Modern, Collaborative SQL GUI to PostgreSQL Developers
Apr 3, 2024 09:00AM Stride Launches First-Ever Independent Worker Contributions Program for Portable Benefits
Apr 2, 2024 08:39PM Form SC 13D/A Adaptimmune Therapeutics Filed by: New Enterprise Associates 14, L.P.
Apr 2, 2024 08:00AM SpyGlass Pharma Unveils Compelling 1-Year Data of Its Innovative Drug Delivery Platform Implanted During Routine Cataract Surgery in Eyes with Glaucoma
Mar 28, 2024 07:26PM Form SC 13D/A Nkarta, Inc. Filed by: New Enterprise Associates 15, L.P.
Mar 27, 2024 02:00PM Kaiser Permanente and Town Hall Ventures launch Habitat Health
Mar 26, 2024 08:00AM Avenzo Therapeutics Announces $150 Million Oversubscribed Financing To Advance Emerging Oncology Pipeline
Mar 21, 2024 04:05PM Regulus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Updates
Mar 19, 2024 09:00AM HEAVY.AI Introduces HeavyIQ, Delivering Powerful Conversational Analytics Focused on Location and Time Data
Mar 13, 2024 10:00AM NEA Appoints Lila Tretikov Partner, Head of AI Strategy
Mar 13, 2024 08:00AM Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
Mar 12, 2024 06:33AM Regulus Therapeutics (RGLS) Enters $100M Oversubscribed Private Placement
Mar 12, 2024 06:32AM Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity
Mar 11, 2024 04:00PM Dr. Laura Shawver to be Recognized as 2024 Duane Roth Endowed Award Lecture Recipient at 20th Annual Industry/Academia Precision Oncology Symposium
Mar 6, 2024 11:13AM Propense.ai Raises $3M in Seed Funding for AI-Driven B2B Cross-Selling Platform
View More Recent Stories View Older Stories